参附汤联合西药治疗急性心肌梗死的临床疗效及对CRP水平的影响  

The efficacy of Shenfu decoction combined with Western medicine for AMI and impact of the combination therapy on CRP level

作　　者：骆明光[1] 林秋波[1] 

机构地区：[1]吴川市人民医院,524500

出　　处：《国际医药卫生导报》2012年第5期686-687,共2页International Medicine and Health Guidance News

摘　　要：目的探讨参附汤联合西药治疗急性心肌梗死（AMI）的临床疗效及对CRP水平的影响。方法将100例AMI随机分为两组，观察组51例，用参附汤联合西药治疗AMI；对照组49例，安慰剂联合西药治疗AMI，观察两组治疗后临床疗效和对CRP水平的影响。结果在改善患者症状和CRP水平的下降指标上，观察组疗效明显优于对照组，观察组总有效率94．12％，总有变化率98．03％，对照组总有效率83．67％，总有变化率91．84％；两组在疗效及CRP水平的影响上差异有统计学意义（P〈0．05）。结论参附汤联合西药治疗AMI起效快、作用强、效果好，对CRP水平的影响显著。Objective To investigate the clinical efficacy of Shenfu decoction combined with Western medicine for acute myocardial infarction （ AMI ） and the effect of the combination therapy on CRP level. Methods 100 patients with AMI were randomly assigned to receive treatment with Western medicine combined with either Shenfu decorction （ 51 patients, study group ）, or placebo （ 49 patients, control group ）. The clinical efficacy and the effect on CRP level were observed in the two groups. Results The study group was obviously superior to the control group in the total effectiveness rate and the rate of CRP reduction （ 94.12% vs. 83.67% and 98.03% vs. 91.84% ）. There were statistical differences in the efficacy and the effect on CRP level （ P 〈 0.05 ）. Conclusions Shenfu delotion combined with westen me- dicine for AMI has a quicker, stronger, better efficacy than Western medicine alone. The effect on CPR level is more significant for combination therapy.

关 键 词：参附汤联合西药 AMI 疗效及对CRP水平的影响 

分 类 号：R542.22[医药卫生—心血管疾病]